인쇄하기
취소
|
A result was out that ‘Actemra(generic name: tocilzumab),’ a JW Pharmaceutical’s interleukin-6 receptor inhibitor, was the most prescribed pharmaceutical product among biologics used as a treatment of rheumatoid arthritis.
It was published in an analytic paper of ‘KOBIO(Korean College of Rheumatology Biologics Registry)’ led by the Clinical Study Committee under the Korean College of Rheumatol...